openPR Logo
Press release

Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psoriasis Market Growth in 2025

09-16-2025 11:39 AM CET | Health & Medicine

Press release from: The Business Research Company

Psoriasis

Psoriasis

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%. Factors such as epidemiology, increased patient awareness and education, and the state of healare infrastructure and access have contributed to this growth during the historical period.

Psoriasis Market Size Forecast: What's the Projected Valuation by 2029?
In the upcoming years, the psoriasis sector is anticipated to witness robust expansion. The market is projected to inflate to "$40.93 billion by 2029, with a CAGR of 9.1%. The escalation in the predicted timeframe is due to regulatory greenlights, patient predilections, a growing elderly population, heightened awareness, and the roll-out of innovative treatments. The key trends expected to shape the forecasted period comprise breakthroughs in R&D, biologics and tailored treatments, orally administered minuscule molecule therapies, custom medicine, digital health and telemedicine, patient-focused care, biosimilars, as well as artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

What Are the Drivers Transforming the Psoriasis Market?
The escalation in the number of psoriasis sufferers is accelerating the Psoriasis market. Psoriasis stems from the immune system, heredity, and surroundings. Factors like climate change, stress, and poor lifestyle have majorly contributed to the increase in psoriasis patients in recent years. As per the data from the World Psoriasis Day consortium, psoriasis affects 125 million people worldwide, which is 2 to 3% of the total population. Consequently, the surge in the number of psoriasis cases is anticipated to boost the Psoriasis market's expansion during the prediction period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Which Emerging Trends Are Transforming the Psoriasis Market in 2025?
The psoriasis market is seeing a rise in the use of combination therapy. This approach entails the simultaneous use of two distinct treatments for psoriasis. When you pair up two drugs with unique action mechanisms (referred to as combination therapy), it has a broader impact than monotherapy, which involves only one drug. Research points out that combination therapy can alleviate psoriasis symptoms more efficiently than a solitary treatment and has fewer side effects. The pairing of taltz (ixekizumab) and methotrexate, contrived by Eli Lilly and Company, is a case in point of combination therapy for active psoriatic arthritis (PsA).

Which Segments in the Psoriasis Market Offer the Most Profit Potential?
The psoriasis market covered in this report is segmented -

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Subsegments:
1) By Interleukin Inhibitors: IL-12/23 Inhibitors (Ustekinumab), IL-17 Inhibitors (Secukinumab, Ixekizumab)
2) By Corticosteroids: Topical Corticosteroids (Hydrocortisone, Betamethasone), Systemic Corticosteroids (Prednisone)
3) By Anti-Inflammatory: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biologic Anti-Inflammatory Agents (Apremilast)
4) By Tumor Necrosis Factor (TNF) Inhibitors: Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2414&type=smp

Which Firms Dominate the Psoriasis Market by Market Share and Revenue in 2025?
Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Which Regions Offer the Highest Growth Potential in the Psoriasis Market?
North America was the largest region in the psoriasis market in 2024. Middle East is expected to be the fastest-growing region in the psoriasis market during the forecast period. The regions covered in the psoriasis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2414

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psoriasis Market Growth in 2025 here

News-ID: 4184433 • Views:

More Releases from The Business Research Company

Leading Companies Bolstering Their Presence in the High Efficiency Energy Car Air Purifier Market
Leading Companies Bolstering Their Presence in the High Efficiency Energy Car Ai …
The high efficiency energy car air purifier industry is gearing up for remarkable growth as innovations and stricter air quality standards reshape the automotive landscape. With increasing attention to cleaner vehicle interiors and advancements in technology, this market is set to expand significantly through the coming decade. Here's an in-depth look at the market size, key players, emerging trends, and segmentation details shaping the future of this sector. Forecasting the High
Top Players and Market Competition in the Heavy-Duty Autonomous Vehicle Industry
Top Players and Market Competition in the Heavy-Duty Autonomous Vehicle Industry
The heavy-duty autonomous vehicle sector is on the brink of significant expansion, driven by technological breakthroughs and increasing acceptance of autonomous solutions in transportation and logistics. This evolving market is set to transform how heavy vehicles operate, promising enhanced efficiency and safety across various industries. Let's explore the market size, influential players, key trends, and segmentation details shaping this dynamic field. Forecasted Expansion in the Heavy-Duty Autonomous Vehicle Market by 2030
Global Drivers Analysis: The Rapid Evolution of the Heavy Duty Trucks Market
Global Drivers Analysis: The Rapid Evolution of the Heavy Duty Trucks Market
The heavy duty trucks market is set to experience consistent expansion over the coming years as it adapts to technological advancements and evolving industry requirements. This growth reflects a broader shift toward cleaner energy sources and smarter transportation solutions, which are transforming how heavy duty trucks operate and serve various applications. Let's explore the market's valuation outlook, influential companies, emerging trends, and segment breakdown in detail. Steady Growth Expected in Heavy
Key Growth Factors, Segment Analysis, and Competitive Approaches Influencing the Headrest Display Market
Key Growth Factors, Segment Analysis, and Competitive Approaches Influencing the …
The headrest display market is poised for significant expansion as technological advancements and consumer preferences push the demand for enhanced in-car entertainment and connectivity. This sector is evolving rapidly, driven by innovations in display technology and the rising integration of digital systems within vehicles, making travel more immersive and engaging for passengers. Projected Market Size and Growth Trajectory of the Headrest Display Market By 2030, the headrest display market is projected

All 5 Releases


More Releases for Psoriasis

Psoriasis Clinical Trial Pipeline Analysis: 65+ Key Companies Shaping the Future …
DelveInsight's Psoriasis Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline psoriasis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the psoriasis pipeline domain. Key takeaways from the Psoriasis Clinical Trial Landscape Report • DelveInsight's psoriasis pipeline report depicts a robust space with 65+ active players working to develop 75+ pipeline therapies for psoriasis treatment. • Key
Psoriasis Vulgaris Market
Introduction Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome. The global psoriasis vulgaris
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Psoriasis Market Size During the Forecast Period? The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally. Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It